136 results
Page 2 of 7
20-F/A
5dkttw 3k562i29zin9
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
jcf1rsi6
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
zqy9ir3qc7dgb4a474e
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
6p0pm
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.5
y1np59w 17g9ki1r9
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
zqbps4g 0phh8nq
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
svrbu0r
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
jdgz95xd9 5gchb
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.2
lqxrru 5jb8kcwv
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.3
tzq095539 9tyx
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.1
a4r1kfr ny9
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
895h0s8t36
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.5
6nokt4v80x19c2xbftd
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
4wjwj
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.1
vphaon6rx
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
mdmv7jri2a0c907966ri
23 Jan 19
51-102F3 Material Change Report
12:44pm